- Home
- BOE vs AVNS Comparison
BOE vs AVNS Comparison
Compare BOE & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOE
- AVNS
- Stock Information
- Founded
- BOE 2005
- AVNS 2014
- Country
- BOE United States
- AVNS United States
- Employees
- BOE N/A
- AVNS N/A
- Industry
- BOE Trusts Except Educational Religious and Charitable
- AVNS Industrial Specialties
- Sector
- BOE Finance
- AVNS Health Care
- Exchange
- BOE Nasdaq
- AVNS Nasdaq
- Market Cap
- BOE 634.0M
- AVNS 641.7M
- IPO Year
- BOE N/A
- AVNS N/A
- Fundamental
- Price
- BOE $11.20
- AVNS $12.07
- Analyst Decision
- BOE
- AVNS
- Analyst Count
- BOE 0
- AVNS 0
- Target Price
- BOE N/A
- AVNS N/A
- AVG Volume (30 Days)
- BOE 166.1K
- AVNS 495.7K
- Earning Date
- BOE 01-01-0001
- AVNS 05-06-2025
- Dividend Yield
- BOE 7.30%
- AVNS N/A
- EPS Growth
- BOE N/A
- AVNS N/A
- EPS
- BOE N/A
- AVNS N/A
- Revenue
- BOE N/A
- AVNS $689,200,000.00
- Revenue This Year
- BOE N/A
- AVNS N/A
- Revenue Next Year
- BOE N/A
- AVNS $3.32
- P/E Ratio
- BOE N/A
- AVNS N/A
- Revenue Growth
- BOE N/A
- AVNS 1.34
- 52 Week Low
- BOE $8.80
- AVNS $11.84
- 52 Week High
- BOE $10.48
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- BOE 59.40
- AVNS 41.63
- Support Level
- BOE $11.07
- AVNS $12.40
- Resistance Level
- BOE $11.39
- AVNS $12.66
- Average True Range (ATR)
- BOE 0.14
- AVNS 0.40
- MACD
- BOE -0.01
- AVNS -0.02
- Stochastic Oscillator
- BOE 45.83
- AVNS 1.91
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.